Read time: 2 minutes. Comprehensive biomarker testing is one of the most powerful tools in modern lung cancer care, guiding treatment decisions and improving patient outcomes. Yet
Read time: 3 minutes. Timely comprehensive biomarker testing has become the cornerstone of precision medicine in lung cancer care. For people diagnosed with non–small cell lung
Read time: 4 minutes. The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts
Read time: 5 minutes. Lung cancer screening has come a long way since low-dose CT (LDCT) scans first became available in 2015 in the United States. However, LDCTs can still miss
Read time: 2 minutes. Last November, Michael O’Donnell was at the Dallas VA during Lung Cancer Awareness Month. It’s where he receives treatment for his lung cancer, but on this
Read time: 5 minutes. In the winter of 2018, I had a lingering cough, nothing out of the ordinary for a Boston winter. At the time, I had just celebrated my first wedding
Read time: 4 minutes. Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal